Editorial for the Special Issue: “Therapeutic Drug Monitoring of Antimicrobials”

A recent guideline [...]

Bibliographic Details
Published in:	Antibiotics
Main Authors:	Matthias Gijsen, Karel Allegaert
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	therapeutic drug monitoring precision dosing antibiotic antifungal antiviral dose optimization
Online Access:	https://www.mdpi.com/2079-6382/11/6/815

Similar Items

Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
by: Heleen Gastmans, et al.
Published: (2022-07-01)

Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients
by: Simon Kallee, et al.
Published: (2022-09-01)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
by: Julie Gorham, et al.
Published: (2023-06-01)

Bayesian model-guided antimicrobial therapy in pediatrics
by: Haden T. Bunn, et al.
Published: (2023-06-01)

Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
by: Justine Heitzmann, et al.
Published: (2022-01-01)

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
by: Kazuaki Matsumoto, et al.
Published: (2022-02-01)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
by: Domenico Umberto De Rose, et al.
Published: (2023-03-01)

Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management
by: Rannissa Puspita Jayanti, et al.
Published: (2022-05-01)

Standards of aminoglycoside therapeutic drug monitoring in a South African private hospital: perspectives and implications
by: Mariette du Toit, et al.
Published: (2019-03-01)

Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations
by: Shelby Barnett, et al.
Published: (2022-01-01)

Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing
by: Ute Chiriac, et al.
Published: (2021-06-01)

Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study
by: Petar G. Vuković, et al.
Published: (2025-09-01)

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring
by: Li Jiang, et al.
Published: (2024-12-01)

Therapeutic drug monitoring for antimicrobial agents for people living with HIV (TAP) [version 2; peer review: 2 approved, 1 approved with reservations]
by: Andrew Kambugu, et al.
Published: (2025-04-01)

Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia
by: Masaki Takigawa, et al.
Published: (2023-04-01)

Development of a neonatal Göttingen Minipig model for dose precision in perinatal asphyxia: technical opportunities, challenges, and potential further steps
by: Marina-Stefania Stroe, et al.
Published: (2023-05-01)

Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review
by: Paula Del Valle-Moreno, et al.
Published: (2023-07-01)

Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic
by: Santiago Grau, et al.
Published: (2021-08-01)

Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy
by: Eman Wehbe, et al.
Published: (2024-05-01)

Broad-Spectrum Activity of Antimicrobial Peptoids
by: Gill Diamond, et al.
Published: (2022-11-01)

A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center
by: Marco Carli, et al.
Published: (2022-01-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates
by: Mario Regazzi, et al.
Published: (2023-12-01)

Editorial: Benefit and risk on drug-drug interactions in infections
by: Hideo Kato, et al.
Published: (2025-04-01)

Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring
by: Wissam K Kabbara, et al.
Published: (2018-11-01)

Therapeutic Drug Monitoring of Antibiotics Is Needed in the Treatment of Sepsis
by: G. P. Plotnikov, et al.
Published: (2022-12-01)

Spatiotemporal urban water profiling for the assessment of environmental and public exposure to antimicrobials (antibiotics, antifungals, and antivirals) in the Eerste River Catchment, South Africa
by: Elizabeth Holton, et al.
Published: (2022-06-01)

Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
by: Eva Choong, et al.
Published: (2022-08-01)

Macrolides: From Toxins to Therapeutics
by: Kiersten D. Lenz, et al.
Published: (2021-05-01)

Population pharmacokinetics of vancomycin in non-extremely preterm neonates based on real-world studies: influence of daily fluid input and diuretics
by: Kai Zhao, et al.
Published: (2025-06-01)

Guidance on Selecting Optimal Steady-State Tacrolimus Concentrations for Continuous IV Perfusion: Insights from Physiologically Based Pharmacokinetic Modeling
by: Romain Martischang, et al.
Published: (2024-08-01)

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis
by: Jérémy Reverchon, et al.
Published: (2022-08-01)

Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing
by: Dzenefa Alihodzic, et al.
Published: (2020-03-01)

Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure
by: Kenneth H. Wills, et al.
Published: (2021-12-01)

Serum concentrations of valproic acid in people with epilepsy: Clinical implication
by: Angel T. Alvarado, et al.
Published: (2022-11-01)

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review
by: Fabio Borgonovo, et al.
Published: (2023-08-01)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
by: Yao Liu, et al.
Published: (2022-10-01)

Therapeutic drug monitoring of methotrexate after its administration in high doses for osteosarcoma treatment in children
by: A. M. Strizhevskaya, et al.
Published: (2020-04-01)

Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole
by: Malene Risum, et al.
Published: (2021-04-01)

Development and Validation of UHPLC-MS/MS Assay for Therapeutic Drug Monitoring of High-dose Methotrexate in Children with Acute Lymphoblastic Leukemia
by: Lian LJ, et al.
Published: (2020-11-01)